📰 Dan Passeri News
Dan Passeri News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dan Passeri. Real-time updates on events, politics, business and more.
November 12, 2023
Operator: Good afternoon, ladies and gentlemen, and welcome to the Cue Biopharma Third Quarter 2023 Earnings Call. At this time, all lines are in listen-only mode.
November 3, 2023
Overall response rate of 47% and disease control rate of 65% in first line recurrent/metastatic HNSCC patients treated with CUE-101 and KEYTRUDA® ORR of 56% in patients with low expression of...
August 10, 2023
Operator: Greetings, and welcome to the Cue Biopharma Investor Update Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the presentation.
December 9, 2022
Additional experts weigh in on Life Science Leader's 2023 finance and funding outlook questions.

May 14, 2021
Newsletter | May 14, 2021 05.14.21 -- mAB Manufacturing, Cell Therapy Platforms, Filling a Vaccine Void and more. Listen to the Business of Biotech Podcast. The Business of Biotech, Biotech with the Bozenhardts, and Life Science Connect. As a member of the Life Science Connect community, you have access to content beyond our weekly newsletters including our podcast series. Don’t forget to subscribe so you never miss an episode! Scott Cleve brings an e...
May 12, 2021
Newsletter | May 12, 2021 05.12.21 -- mAB Manufacturing, Cell Therapy Platforms, Filling a Vaccine Void and more. Listen to the Business of Biotech Podcast. The Business of Biotech, Biotech with the Bozenhardts, and Life Science Connect. As a member of the Life Science Connect community, you have access to content beyond our weekly newsletters including our podcast series. Don’t forget to subscribe so you never miss an episode! Scott Cleve brings an e...